OR WAIT null SECS
August 04, 2023
Under a manufacturing agreement, Northway Biotech will develop a manufacturing process for iTolerance’s fusion protein in development for regenerative therapy.
August 03, 2023
Waters XBridge Premier GTx BEH size exclusion chromatography (SEC) columns are designed to improve analysis while lowering the cost of gene therapies.
Kiefel’s new machine is designed to form, fill, and seal up to 6,000 infusion, parenteral nutrition, or dialysis bags per hour.
The nasal-spray drug can be used to reverse the effects of opioid overdose.
Laboratories are focusing on more automated processes while also trying to maintain an efficient, safe, and personalized experience with each analytical test.
August 02, 2023
Only a significant joint effort across the supply chain will help to make healthcare more sustainable and reduce the impact of climate change on global health.
August 01, 2023
The program aims to aid submissions from external stakeholders and FDA staff.
Biogen’s acquisition of Reata will grant them access to Reata’s FDA-approved treatment for Friedreich’s ataxia.
AstraZeneca, via its subsidiary Alexion Pharmaceuticals, will purchase a portfolio of preclinical rare disease gene therapies from Pfizer in a deal worth up to $1 billion.
The guidance document outlines recommendations to limit potential carcinogenic risk.